Article Information
History
- June 17, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Aidan M. Tousley1,
- Maria Caterina Rotiroti1,
- Louai Labanieh2,3,
- Lea Wenting Rysavy1,
- Skyler P. Rietberg4,
- Eva L. de la Serna5,
- Guillermo Nicolas Dalton1,
- Dorota Klysz4,
- Evan W. Weber3,4,
- Won-Ju Kim1,
- Peng Xu4,
- Elena Sotillo4,
- Alexander R. Dunn5,7,8,
- Crystal L. Mackall1,3,4,9 and
- Robbie G. Majzner1,3,4,*
- 1Department of Pediatrics, Stanford University School of Medicine, Stanford, California
- 2Department of Bioengineering, Stanford University, Stanford, California
- 3Parker Institute for Cancer Immunotherapy, San Francisco, California
- 4Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California
- 5Department of Chemical Engineering, Stanford University, Stanford, California
- 6Parker Institute for Cancer Immunotherapy, San Francisco, California
- 7Stanford Cardiovascular Institute, Stanford School of Medicine, Stanford, California
- 8Biophysics Program, Stanford University, Stanford, California
- 9Department of Medicine, Stanford University School of Medicine, Stanford, California
- ↵*To whom correspondence should be addressed: rmajzner{at}stanford.edu